Status:
COMPLETED
The Effects of Lifebloom One on Physical Activity After Acquired Brain Injury
Lead Sponsor:
Lifebloom
Collaborating Sponsors:
Pitié-Salpêtrière Hospital
Conditions:
Stroke
Brain Injuries, Traumatic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to evaluate the effects of Lifebloom One in people who have suffered a stroke or a traumatic brain injury. The main questions to be answered are: * Does Lifebloom ...
Eligibility Criteria
Inclusion
- Stroke or traumatic brain injury more than 2 months old
- Unable to walk without assistance
- Expected length of stay equal to or greater than 4 months
Exclusion
- Anthropometric incompatibility with Oxilio
- Unable to walk prior to brain injury
- No functional upper limb
- Complete sensory deficit in the lower limb(s)
- Degenerative impairment (tumor, neurodegenerative disease, etc.)
Key Trial Info
Start Date :
September 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05977270
Start Date
September 15 2023
End Date
August 29 2024
Last Update
March 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Physical Medicine and Rehabilitation Department - Pitié-Salpêtrière Hospital
Paris, France, 75013